These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 10037166

  • 1. Clozapine for refractory schizophrenia: the Illinois experience.
    Buckman RW, Malan RD.
    J Clin Psychiatry; 1999; 60 Suppl 1():18-22; discussion 28-30. PubMed ID: 10037166
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. New vs. old antipsychotics: the Texas experience.
    Reid WH.
    J Clin Psychiatry; 1999; 60 Suppl 1():23-5; discussion 28-30. PubMed ID: 10037167
    [Abstract] [Full Text] [Related]

  • 4. A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.
    Rosenheck R, Cramer J, Xu W, Thomas J, Henderson W, Frisman L, Fye C, Charney D.
    N Engl J Med; 1997 Sep 18; 337(12):809-15. PubMed ID: 9295240
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [The impact of antipsychotic medication on the incidence and the costs of inpatient treatment in people with schizophrenia: results from a prospective observational study].
    Kilian R, Angermeyer MC.
    Psychiatr Prax; 2004 Apr 18; 31(3):138-46. PubMed ID: 15042477
    [Abstract] [Full Text] [Related]

  • 11. Pharmacoeconomic evaluation of clozapine in treatment-resistant schizophrenia: a cost-utility analysis.
    Oh PI, Iskedjian M, Addis A, Lanctôt K, Einarson TR.
    Can J Clin Pharmacol; 2001 Apr 18; 8(4):199-206. PubMed ID: 11743592
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacoeconomic evaluation of treatments for refractory schizophrenia: clozapine-related studies.
    Revicki DA.
    J Clin Psychiatry; 1999 Apr 18; 60 Suppl 1():7-11; discussion 28-30. PubMed ID: 10037164
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. New antipsychotic agents: emerging clinical profiles.
    Buckley PF.
    J Clin Psychiatry; 1999 Apr 18; 60 Suppl 1():12-7; discussion 28-30. PubMed ID: 10037165
    [Abstract] [Full Text] [Related]

  • 16. Should clozapine continue to be restricted to third-line status for schizophrenia?: a decision-analytic model.
    Wang PS, Ganz DA, Benner JS, Glynn RJ, Avorn J.
    J Ment Health Policy Econ; 2004 Jun 18; 7(2):77-85. PubMed ID: 15208468
    [Abstract] [Full Text] [Related]

  • 17. A pharmacoeconomic evaluation of clozapine in one patient.
    Rémillard AJ, Johnson JA.
    Can J Hosp Pharm; 1993 Jun 18; 46(3):115-9. PubMed ID: 10126866
    [Abstract] [Full Text] [Related]

  • 18. [Medical economic impact of schizophrenia].
    Martin P.
    Encephale; 1995 Jun 18; 21 Spec No 3():67-73. PubMed ID: 7628346
    [Abstract] [Full Text] [Related]

  • 19. Outcome in schizophrenia: beyond symptom reduction.
    Meltzer HY.
    J Clin Psychiatry; 1999 Jun 18; 60 Suppl 3():3-7; discussion 8. PubMed ID: 10073370
    [Abstract] [Full Text] [Related]

  • 20. Cost effectiveness of clozapine in neuroleptic-resistant schizophrenia.
    Meltzer HY, Cola P, Way L, Thompson PA, Bastani B, Davies MA, Snitz B.
    Am J Psychiatry; 1993 Nov 18; 150(11):1630-8. PubMed ID: 8105705
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.